Filing Flows › Mimedx Group (MDXG) › Q1 2026
Mimedx Group (MDXG) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 29, 2026
Mimedx Group (MDXG) reported revenue of $59.0M for the first quarter 2026 (Q1 2026), -33% from a year earlier and -50% from the quarter before. Operating margin was -27.2%, net loss $10.9M (18.4% of revenue).
Mimedx Group, Q1 2026: revenue $59.0M (-33% year over year), operating margin -27.2%, net loss $10.9M, operating cash flow $1.9M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $59.0M | -50% | -33% |
| Operating profit | −$16.0M | -176% | -295% |
| Net earnings | −$10.9M | -171% | -255% |
| Operating cash flow | $1.9M | -92% | -65% |
| Free cash flow | $1.3M | — | -73% |
What changed
Revenue was $59.0M in Q1 2026, down 33% year over year and down 50% from the previous quarter. Surgical was the largest line at 62% of revenue. Wound lost $33.5M year over year (down 60%), 115% of the total change.
Gross margin was 70.6%, down 10.7 points from Q1 2025. Operating costs exceeded revenue by $16.0M, an operating margin of -27.2%. Operating expenses fell 9% while revenue fell 33%. The fastest-growing cost line was Research & development (+24%). The quarter ended with a net loss of $10.9M, after a profit of $15.2M the previous quarter.
Operating cash flow was $1.9M (down 65% year over year). Non-cash charges added back $829K of depreciation and amortization. Working capital and other items added $11.9M. Capital expenditures of $570K left free cash flow of $1.3M.
Questions
What was Mimedx Group's revenue in the first quarter 2026?
Mimedx Group (MDXG) reported revenue of $59.0M for the first quarter 2026 (Q1 2026), -33% from a year earlier and -50% from the quarter before.
Was Mimedx Group profitable in the first quarter 2026?
Operating loss was $16.0M (-27.2% of revenue) and net loss $10.9M.
Source: Mimedx Group 10-Q on SEC EDGAR.